Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 16374089

Do progressive tension sutures really decrease complications in abdominoplasty?

Sami Khan·Sumeet S Teotia·William F Mullis·William E Jacobs·Michael E Beasley·Kevin L Smith·Felmont F Eaves·Stephan J Finical·Paul A Watterson
View original source ↗Export metadata ↓

Abstract

The purpose of this study is to evaluate the efficacy of progressive tension sutures (PTS) in preventing or reducing seroma formation and local wound complications in patients undergoing abdominoplasty. Forty-nine patients who underwent abdominoplasty procedures with the use of PTS were retrospectively compared with a historical control group of 54 patients who underwent standard abdominoplasty. Primary outcomes measured were seroma formation and local wound complications, including hypertrophic scar formation, umbilical distortion, and wound necrosis. Secondary outcomes were all other complications and time to drain removal. Overall complication rates and local wound complication rates were significantly reduced with the addition of PTS to abdominoplasty. Seroma formation and the time to drain removal were reduced in the PTS group, but the findings were not statistically significant.

Explore related subjects

AbdomenAdultDemographyDrainageFemaleFollow-Up StudiesHumansIncidenceMalePostoperative ComplicationsPlastic Surgery ProceduresSuture TechniquesSuturesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sami Khan, Sumeet S Teotia, William F Mullis, William E Jacobs, Michael E Beasley, Kevin L Smith, Felmont F Eaves, Stephan J Finical, Paul A Watterson. 2006. Do progressive tension sutures really decrease complications in abdominoplasty?. https://doi.org/10.1097/01.sap.0000194333.04545.5f

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

C-reactive protein and metabolic syndrome in women with previous gestational diabetes.

BACKGROUND: This study evaluates the presence of metabolic syndrome (MS) and its association with C-reactive protein (CRP) and other cardiovascular (CV) risk factors, in a sample of women with and without previous Gestational Diabetes (pGDM). METHODS: One hundred and sixty-six women with pGDM and 98 women (controls) with uncomplicated pregnancy were studied 16 months after delivery. In all women, plasma glucose, insulin, lipid profile, serum uric acid, C-reactive protein, fibrinogen and homocysteine were measured. MS was defined according to NCEP ATPIII criteria. RESULTS: MS was identified in 15 pGDM women (9%) versus 1 control (1%) (p < 0.001). The more frequent metabolic traits were abdominal obesity (36% vs 17%) and low HDL-cholesterol (34% vs 17% in pGDM women and controls, respectively; all p < 0.01). HOMA-R, LDL-cholesterol, fibrinogen, serum uric acid and CRP resulted significantly higher in pGDM women with MS as compared to those without MS after adjustment for BMI. In women with no criteria for MS, only CRP levels were found to be higher in pGDM women compared to controls (p < 0.05). Seventeen percent of pGDM women with no criteria for MS had CRP levels >or=1 mg/L (all controls showed CRP levels <1 mg/L). After a stepwise regression analysis, CRP levels were independently correlated to HOMA-R (r2 = 0.27, p < 0.001) and fibrinogen (r2 = 0.30, p < 0.001). CONCLUSIONS: In our population, MS occurs in a sizable proportion of pGDM women and is associated with increased levels of CRP, fibrinogen, uric acid and LDL-cholesterol. Moreover, higher levels of CRP, a marker of chronic low-grade inflammation, are present in a subset of women with pGDM, independently of MS.

Abdomen↗
PubMed2007

In vivo performance of antibiotic embedded electrospun PCL membranes for prevention of abdominal adhesions.

The aim of this study was to prepare nonwoven materials from poly(epsilon-caprolactone) (PCL) and their antibiotic containing forms by electrospinning, so as to prevent postsurgery induced abdominal adhesions in rats. epsilon-Caprolactone was first polymerized by ring-opening polymerization, and then it was processed into matrices composed of nanofibers by electrospinning. A model antibiotic (Biteral) was embedded within a group of PCL membranes. In the rat model, defects on the abdominal walls in the peritoneum were made to induce adhesion. The plain or antibiotic embedded PCL membranes were implanted on the right side of the abdominal wall. No membrane implantation was made on the left side of the abdominal wall that served as control. Macroscopical and histological evaluations showed that using these barriers reduces the extent, type, and tenacity of adhesion. The antibiotic embedded membranes significantly eliminated postsurgery abdominal adhesions, and also improved healing.

Abdomen↗
PubMed2007

Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.

BACKGROUND: Ifosfamide is widely used in paediatric oncology, but its use is limited by nephrotoxic side effects. The aim of this study was to evaluate the incidence and risk factors of tubulopathy, with special emphasis on the influence of age, where different findings have been published so far. PROCEDURE: Five hundred ninety three children and adolescents treated for Ewing, osteo- or soft-tissue sarcoma (median age at diagnosis: 11.7 years) were prospectively investigated for nephrotoxicity in the Late Effects Surveillance System (LESS) study. Tubulopathy was diagnosed in case of continuing hypophosphatemia and proteinuria. RESULTS: After a median follow up of 19 months, 27 patients (4.6%; 95% CI: 3.0-6.6%) had newly developed tubulopathy. This incidence was 0.4% (95% CI: 0-2.4%) in patients treated with a cumulative ifosfamide dose of < or =24 g/m2, 6.5% (95% CI: 3.6-10.7%) after 24-60 g/m2, and 8.0% (95% CI: 4.2-13.6%) after > or = 60 g/m2. In multivariate analysis, children younger than 4 years at time of diagnosis had an 8.7-fold (95% CI: 3.5-21.8) higher risk for tubulopathy than older patients. Neither carboplatin treatment nor abdominal irradiation showed any significant influence. CONCLUSION: Ifosfamide-induced nephrotoxicity was found in 4.6% of patients. Risk factors were the cumulative ifosfamide dose and young age at treatment.

Abdomen↗